| | ||||||||||
| 1 | INN | Class | Route (list) | PK parameters= Cmax; Tmax; F: bioavailability; t1/2: half-life; VD: volume of distribution; Cl: clearance; PPB: plasma protein binding;(EQN means that value was calculated using VD=(Cl*t1/2)/0.693) | Primary Target and PDB code of Protein-Drug complex | Targets from DrugCentral | Links | |||
| BRINCIDOFOVIR (has an active metabolite)
| BRINCIDOFOVIR | ANTIINFECTIVES | ORAL | Cmax 854.5 NANOMOLAR Tmax 3 HOUR F 16.8 PERCENT VD 1230 LITER PPB 99.9 PERCENT Cl 44.1 LITER / HOUR HT 19.3 HOUR SOLUBILITY PRACTICALLY INSOLUBLE IN WATER | DNA POLYMERASE | - more at DrugCentral | EMA | |||
| 2 | INN | Class | Route (list) | PK parameters= Cmax; Tmax; F: bioavailability; t1/2: half-life; VD: volume of distribution; Cl: clearance; PPB: plasma protein binding;(EQN means that value was calculated using VD=(Cl*t1/2)/0.693) | Primary Target and PDB code of Protein-Drug complex | Targets from DrugCentral | Links | |||
| CIDOFOVIR (is an active metabolite) (has an active metabolite)
| CIDOFOVIR | ANTIINFECTIVES | INJECTION | Cmax 70.2 MICROMOLAR VD 26.6 LITER (65 KILOGRAM) PPB 6 PERCENT Cl 8.8 LITER / HOUR HT 2.6 HOUR SOLUBILITY 170 MILLIGRAM / MILLILITER IN WATER | DNA POLYMERASE PDB 5KM8 (HUMAN HISTIDINE TRIAD NUCLEOTIDE BINDING PROTEIN 2 (HHINT2) CIDOFOVIR COMPLEX) LIGAND CODE = L8P (link to the list of PDB complexes) Download experimental 3D coordinates of L8P with added hydrogens | DNA polymerase catalytic subunit UNIPROT P04293 more at DrugCentral | EMA | |||
| 3 | INN | Class | Route (list) | PK parameters= Cmax; Tmax; F: bioavailability; t1/2: half-life; VD: volume of distribution; Cl: clearance; PPB: plasma protein binding;(EQN means that value was calculated using VD=(Cl*t1/2)/0.693) | Primary Target and PDB code of Protein-Drug complex | Targets from DrugCentral | Links | |||
| M CIDOFOVIR (is an active metabolite)
| CIDOFOVIR | ANTIINFECTIVES | - | DNA POLYMERASE | DNA polymerase catalytic subunit UNIPROT P04293 more at DrugCentral | EMA | ||||
